Today: 26 June 2026
Browse Category

Stock Market 27 January 2026

Gilead stock hits fresh 52-week high as Wall Street lifts targets into earnings

Gilead stock hits fresh 52-week high as Wall Street lifts targets into earnings

Gilead Sciences shares rose 1.8% to $140.24 Tuesday afternoon, hitting a 12-month high of $141.69 earlier in the session. Citi, Truist, and BMO raised price targets following upbeat analyst notes and strong momentum for the company’s HIV prevention drug Yeztugo. Investors await early February results and Gilead’s earnings, expected around Feb. 10.
Arista Networks stock extends rally after Microsoft’s Maia 200 launch puts AI networking back in focus

Arista Networks stock extends rally after Microsoft’s Maia 200 launch puts AI networking back in focus

Arista Networks shares rose nearly 2% to $146.62 Tuesday, extending a 5.4% jump from the previous session and lifting its market value to about $183 billion. The gains followed Microsoft’s launch of the Maia 200 AI chip, which relies on Ethernet networking, and a bullish analyst note highlighting benefits for Arista. Investors await Microsoft’s earnings Jan. 28 and Arista’s report Feb. 12.
Applied Materials stock jumps nearly 5% as Micron’s Singapore expansion lifts chip-tool shares

Applied Materials stock jumps nearly 5% as Micron’s Singapore expansion lifts chip-tool shares

Applied Materials jumped 4.8% to $334.84 after Micron announced a $24 billion memory plant in Singapore, signaling higher chip equipment demand. Sector peers Lam Research, KLA, and ASML also advanced. Analysts expect enterprise SSD prices to surge as supply tightens. Investors await the Fed’s rate decision Wednesday and ASML’s earnings for clues on 2026 demand.
Home Depot stock price slips as contractor AI tool launches and the Fed looms

Home Depot stock price slips as contractor AI tool launches and the Fed looms

Home Depot shares fell 1.9% to $379.20 Tuesday, underperforming as housing-related stocks declined. The drop followed weak U.S. consumer confidence data, which hit its lowest since 2014. On Monday, Home Depot launched its “Material List Builder AI” tool for professional users. Investors are watching for Wednesday’s Fed decision and Home Depot’s Feb. 24 earnings report.
Chevron stock price edges up on Iraq oilfield talks, Venezuela sanctions shift ahead of earnings

Chevron stock price edges up on Iraq oilfield talks, Venezuela sanctions shift ahead of earnings

Chevron shares rose 0.3% to $167.93 Tuesday as investors watched talks over Iraq’s West Qurna 2 oilfield and higher crude prices following U.S. supply disruptions. Reuters reported Chevron is seeking improved terms from Iraq before taking over the field from Lukoil, which faces a Feb. 28 sanctions deadline. The U.S. is also preparing a broader Venezuela license that could affect Chevron’s operations. Quarterly results are due Friday.
AI stocks rise as Nvidia and Microsoft climb into earnings week — what investors watch next

AI stocks rise as Nvidia and Microsoft climb into earnings week — what investors watch next

Nvidia rose 1.7% and Microsoft gained 2.3% Tuesday as AI-linked stocks outperformed the broader market. S&P Global estimates capex by major tech firms jumped over $45 billion in 2025, with total spending expected to approach $500 billion in 2026. Microsoft unveiled its Maia 200 AI chip, set to launch in Iowa and Arizona data centers. Meta and Microsoft report earnings Wednesday, with investor focus on AI investment returns.
Caterpillar stock rises after Jefferies lifts CAT target to $750, with earnings next

Caterpillar stock rises after Jefferies lifts CAT target to $750, with earnings next

Caterpillar shares rose about 0.4% to $638.49 Tuesday after Jefferies raised its price target to $750 and kept a Buy rating. The company reports fourth-quarter and full-year earnings Thursday morning. Wall Street expects earnings of $4.67 per share on $17.89 billion in revenue. Investors are watching for the Fed’s rate decision Wednesday and ongoing tariff impacts on industrials.
27 January 2026
Redwire (RDW) stock jumps nearly 28% after landing $151 billion SHIELD defense contract slot

Redwire (RDW) stock jumps nearly 28% after landing $151 billion SHIELD defense contract slot

Redwire Corporation shares jumped nearly 28% to $14.01 Tuesday after announcing a spot on the Missile Defense Agency’s $151 billion SHIELD contract vehicle. The stock hit $14.54 intraday on heavy volume. The award is multi-vendor and does not guarantee revenue, Redwire said. Traders are watching for follow-up task orders and any impact on Redwire’s backlog or sales.
Salesforce stock flips lower after $5.6B U.S. Army deal headline — what’s next for CRM shares

Salesforce stock flips lower after $5.6B U.S. Army deal headline — what’s next for CRM shares

Salesforce shares fell 0.4% to $228.39 after news of a 10-year U.S. Army contract capped at $5.6 billion. The deal, awarded to Salesforce’s Computable Insights unit, allows the Army to order services as needed but does not guarantee the full amount will be spent. The contract includes a five-year base period with a five-year option. Salesforce will report earnings around Feb. 25.
27 January 2026

Stock Market Today

  • Zacks Starts Coverage on Versus Systems Highlighting Gamification Strategy
    June 26, 2026, 1:18 PM EDT. Zacks Investment Research has initiated coverage on Versus Systems (NASDAQ: VS), spotlighting the company's progress in gamification and audience engagement. Based in Austin, Texas, Versus Systems is advancing its platform that integrates gaming elements into non-gaming contexts to boost user interaction. Zacks sees potential growth driven by expanding adoption of gamification in marketing and entertainment sectors. This move reflects increasing investor interest in companies leveraging technology to enhance consumer engagement. Versus Systems aims to capitalize on these trends as it broadens its market reach and product offerings.

Latest News

Moderna (NASDAQ:MRNA) gains $3.3 billion after CAR-T update

Moderna (NASDAQ:MRNA) gains $3.3 billion after CAR-T update

26 June 2026
Moderna soared 13.9% to $68.06 after unveiling mRNA-6007, an in vivo CAR-T candidate for autoimmune disease, at its Science Day, adding $3.3 billion in equity value—more than its 2026 R&D forecast—despite no near-term sales boost, with analysts split on future prospects and cash burn risks.
Go toTop